Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1862103 (
BDC
)
459
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Herein, we present a new method for preparing homoligand 3D coordination polymers. First, a layered metal-organic framework Zn3(
BDC
)3(H2O)2 x 4DMF 1 (
BDC
is terephthalate, DMF is N,N-dimethylformamide) was fabricated from a H2BDC by liquid-liquid diffusion. Second, the layered product, 1, was used as a precursor to solvothermally react with further H2BDC at 140-180 degrees C, resulting in two products of
BDC
insertion into the layered structure. These are [Zn3(p-BDC)4] x 2HPIP, 2 (
HPIP
is partly protonated piperazine), and [Zn3(p-BDC)3(H2BDC)] x (C6H15NO) x H2O x 3DMF, 3 (C6H15NO is triethylamine N-oxide). Single-crystal X-ray diffraction shows that 2 possesses a layer-pillared structure of mu4-
BDC
, with 1D channels, while 3 has a layer-pillared structure of mu2-
BDC
, with 2D channels. N2-sorption experiments show 3 has a relatively high BET surface area of 750 m(2)/g. It is proposed that 2 follows the crystal growth mechanism of Ostwald ripening, whereas the crystal structure of 3 might be formed by an insertion mechanism.
...
PMID:Construction of 3D layer-pillared homoligand coordination polymers from a 2D layered precursor. 1702 79